U.S. stock market abnormal movement | Share price continues to plummet! Regen Corporation (RGC.US) plunges over 30%

According to the Securities Times app, after a sharp drop of 40% last Friday, on Monday, Regen Cybernetics Corporation (RGC.US) once again fell by over 30%, closing at $26.42. It is reported that Regen Cybernetics Corporation is an early-stage biotechnology company focused on the research and commercialization of traditional Chinese medicine for the treatment of neurological cognitive disorders and degenerative diseases, especially attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).